Medicare billing address
CMS Medicare provider billing file
2800 Hayes Ave Bldg CSandusky, OH 44870
CMS public data · NPI 1093814220
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Todd E Rambasek, MD
Specialty
Credential
MD
NPI
1093814220
Primary source state
OH
Data retrieval date
July 27, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Todd E Rambasek, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
2800 Hayes Ave Bldg CCMS Doctors & Clinicians file
2800 Hayes AveIn the 2024 CMS provider billing file, this NPI had 338 Medicare beneficiaries and 32,818 total services. The average beneficiary age was 72, and the average HCC risk score was 1.2.
Total Medicare allowed amount
$887,526.31
Total Medicare payment amount
$695,182.03
Medicare beneficiaries
338
Total services
32,818
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
73%
CMS beneficiary-panel share
Asthma
38%
CMS beneficiary-panel share
Anxiety
28%
CMS beneficiary-panel share
Diabetes
26%
CMS beneficiary-panel share
COPD
22%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, omalizumab, 5 mg | 10,380 | $35.62 |
| Test for allergy using allergenic extract | 3,235 | $3.42 |
| Test for allergy using allergenic extract injected into skin | 729 | $7.25 |
| Test for allergy using skin patch | 628 | $4.67 |
| Professional service for preparation and provision of 1 or more antigens | 522 | $13.71 |
| Professional service for multiple injections of allergen | 471 | $11.32 |
| Injection of drug or substance under skin or into muscle | 417 | $13.77 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 232 | $87.88 |
| Professional service for single injection of allergen | 139 | $9.54 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 126 | $124.65 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1093814220. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Ipratropium Bromide | Ipratropium Bromide | 328 | 429.7 | $13,237.28 |
| 2 | Montelukast Sodium | Montelukast Sodium | 240 | 523.1 | $2,770.00 |
| 3 | Azelastine Hcl | Azelastine Hcl | 236 | 517.7 | $11,514.45 |
| 4 | Fluticasone Propionate | Fluticasone Propionate | 204 | 427.7 | $3,741.63 |
| 5 | Famotidine | Famotidine | 123 | 268 | $1,718.91 |
| 6 | Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 101 | 137 | $85,728.11 |
| 7 | Breo Ellipta | Fluticasone/Vilanterol | 91 | 159 | $62,272.90 |
| 8 | Albuterol Sulfate Hfa | Albuterol Sulfate | 71 | 71.9 | $945.09 |
| 9 | Triamcinolone Acetonide | Triamcinolone Acetonide | 63 | 64.9 | $685.96 |
| 10 | Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 62 | 82 | $7,150.62 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Clvlnd Clinic Lerner College Of Med Of Case Wstn Rsv University
Graduation year
1998
Group/practice field
Northern Ohio Medical Specialists, Llc
Telehealth reported
Yes
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.